Parkinson’s Disease Parkinson’s Disease (PD), known for its degenerative abilities and debilitating affects, is an illness that affects approximately 1 million Americans. The cause of this disease has not been pinpointed, although strides have been made towards a cure. As our elderly population increases, so does our overwhelming need to find a suitable cure that may one day eliminate this disease. Concepts of PD After watching the video: My father, My Brother, and Me, viewable at www.pbs
Parkinson's Disease Parkinson's is an idiopathic, multifactorial neurodegenerative disease that attacks neurotransmitters in the brain called dopamine. Dopamine is concentrated in a specific area of the brain called the substantia nigra. The neurotransmitter dopamine is a chemical that regulates muscle movement and emotion. Dopamine is responsible for relaying messages between the substantia nigra and other parts of the brain to control body movement. The death of these neurotransmitters affects
Nurse’s play a very important role in the delivery of care to an older person and in complex disease such as Parkinson’s disease, the care provided by a nurse is vital for both the patient and the family of the affected person. The aim of this essay is to understand briefly about Parkinson’s disease and associated issues and the role of the nurse in the management of the condition. Parkinson’s disease is a chronic, progressive neurodegenerative disorder characterised by resting tremor, slowed movements
Parkinson’s disease (PD) is the second most common neurodegenerative disease in the country. It is characterized by tremor, rigidity, bradykinesia, and impaired muscular coordination (Wei et al., 2014). It affects approximately 50 out of every 100,000 people over the age of fifty. PD can occur sporadically, but affects one third of people who have two or more first-degree relatives with the disease (Duffy, 2005, p. 190). Several systems are affected in the population of those with Parkinson’s disease
Parkinson’s disease (PD) is a progressive and chronic neurodegenerative disorder. The disease is named after English physician James Parkinson, who made a detailed description of the disease in his essay: "An Essay on the Shaking Palsy" (1817). Parkinson 's disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and, in extreme cases, a loss of physical movement (akinesia) (Sue, Sue, Sue & Sue
Parkinson’s disease is one of the most common nervous system disorders. This disease is part of a group of conditions that are referred to as motor system disorders. Motor system disorders are the result of the loss of dopamine producing brain cells. Dopamine is a neurotransmitter. It acts as the chemical messenger in the transmission of signals in the brain and other vial areas. Dopamine is found in humans as well as animals, including both vertebrates and invertebrates. Further information
Current research on Parkinson’s disease (PD) examines the effects of deteriorating dopaminergic neurons in the substantia nigra causing modifications in the basal ganglia circuitry1. The prevailing model behind this understanding is the classical model: activation of the direct pathway MSNs stimulates movement while activation of the indirect inhibits4. The idea is that motor deficits observed in PD are caused by an underactive direct pathway and an overactive indirect pathway. This research examined
Parkinson's Disease Parkinson’s Disease (PD), "the shaking palsy" first described by James Parkinson in 1817, is a progressive neurodegenerative disorder which affects in upwards of 1.5 million Americans. The disease begins to occur around age 40 and has incidence with patient age. One survey found that PD may affect 1% of the population over 60. Incidence seems to be more prominent in men, and tends to progress to incapacity and death over one or two decades. Clinical diagnosis of PD is
Parkinson’s Disease Parkinson’s disease, a chronic, progressive, and neurodegenerative brain disorder affecting body movement, known to have no cure, yet has treatments that will help in managing the disease. This disease is named after James Parkinson, an English physician who described this illness. Approximately one million people in the United States are diagnosed with Parkinson’s disease (What is Parkinson’s, n.d.). This disease is identified to be slow in progression and symptoms of this will
discusses one of the most common disease of the elderly naming Parkinson's Disease. This paper reflects the basic understanding of the disease with prime focus on the course, treatment and advance health care needs of the patient. Additionally, to have a better understanding of the disease this paper puts some light on the causes and pathogenesis of the disease and how an elderly patient can cope up with his life during the last stages of the disease. Key Words Parkinson's disease, Elderly patient, Bradykinesia
Background Parkinson’s Disease (PD) is a neurodegenerative disease, meaning that it slowly progresses as the brain’s cells lose function or structure (National Parkinson Foundation [NPF], 2014). Parkinson’s disease is a condition affecting movement, also known as a movement disorder (National Library of Medicine [NLM], 2014). Parkinson’s involves the failure and death of the neurons in the brain that control movement and coordination. The neurons that are primarily affected are the substania nigra
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor dysfunctions including: tremors at rest, difficulty initiating and executing voluntary movements, slowed movements (bradykinesia), muscular rigidity and postural instability. The specific cause of the Parkinson’s disease is still unknown; many scientists have found correlations of genetic, environmental (toxins), and lifestyle factors (stressful life events and nutrition) with increased risks of PD. Parkinson’s disease
Parkinson's disease is a progressive neurological degenerative disorder that affects movement. It was discovered and analyze by James Parkinson in 1817. This disease is a progressive disease; it gets worse with the passing of the years. The disease itself is not deadly, but it has serious side effects. The CDC rated these complications as the 14th cause of deaths in the U.S. The average age of diagnostic of PD is 62. Any person diagnosed before 50 is considered to have Young-Onset Parkinson's Disease
Parkinsonism: - Parkinsonism is a disorder of extrapyramidal system, characterized by tremor, rigidity, bradykinesia and postural disturbance. Parkinson’s disease (Paralysis Agitans) Parkinson’s disease (PD) most commonly affects person over the age of 55 year, and is characterized by: bradykinesia, rest tremor, rigidity and postural instability. (At least two of these and a response to levodopa should be usually present to make the diagnosis). The substantia nigra has two parts, the pars reticulata
The chronic disease I am researching and writing about is named Parkinson's disease (PD). By definition, Parkinson’s disease is a slowly progressive neurologic disease characterized by an expressionless face, tremor at rest, slowing of voluntary movements, walking manners are with short accelerating steps, peculiar posture and muscle weakness, caused by degeneration of an area of the brain known as the basal ganglia, and low production of the neurotransmitter dopamine (basically a chemical released
Parkinson’s disease is a neurodegenerative brain disorder. This disease is both chronic and progressive in nature. In this disease, the brain slowly stops producing dopamine, a neurotransmitter that regulates body movements and emotions. This disease can present itself in many different symptoms, but the four main motor symptoms are: tremors at rest, slowness of movement, stiffness in arms and legs, and trouble with balance. Other symptoms like depression and anxiety often accompany Parkinson’s
Melissa. Parkinson's Disease. San Diego, CA: Thomson/Gale, 2005. Print. Goldmann, David R., and David A. Horowitz. American College of Physicians Home Medical Guide to Parkinson's Disease. New York: Dorling Kindersley Pub., 2000. Print. Mandal, Ananya. "Parkinson's Disease History." News-Medical.net. N.p., 2013. Web. 08 Oct. 2016. ParkinsonDotOrg. "National Parkinson Foundation: Believe in Better." National Parkinson Foundation. N.p., n.d. Web. 02 Oct. 2016.Biology Research Paper: Parkinson’s Disease
Many people around the world today suffer from Parkinson’s disease and other movement disorders. A movement disorder is a disorder impairing the speed, fluency, quality, and ease of movement. There are many types of movement disorders such as impaired fluency and speed of movement (dyskinesia), excessive movements (hyperkinesia), and slurred movements (hypokinesia). Some types of movement disorders are ataxia, a lack of coordination, Huntington's disease, multiple system atrophies, myoclonus, brief
Biology 2 October 2017 The Mitochondria and Parkinson’s Disease The mitochondria. We all know it as the “powerhouse of the cell.” However, if the Mitochondria fails, there is a chance of the body developing nasty diseases - such as Parkinson’s Disease. Parkinson’s Disease Parkinson’s Disease is a chronic movement disorder that is progressive, meaning it gets worse over time. According to the Parkinson’s Disease Foundation website, “Parkinson’s involves the malfunction and death of vital nerve
experiencing the intial effects of Parkinson’s disease. Originally called “Shaking Palsy” due to body tremors, Parkinson’s disease is a progressive neurological disorder of the central nervous system that affects movement. Named by Dr. James Parkinson, Parkinson’s disease is a very serious disease. Many things are associated with Parkinson’s disease and in this essay you’ll learn all about them. This is Parkinson’s With more than 200,000 US cases per year, Parkinson’s disease has become a major part in